ReUnite Oncofertility

Cancer Patients Save on Select Medications

Cancer treatments can impact a woman’s fertility. Fortunately, fertility preservation options exist, but generally the costs are not covered by insurance. ReUnite Oncofertility helps to reduce the costs for fertility preservation by offering a discount of up to 100% on select medications. The discount a patient receives is determined by her level of financial need.

Eligible Medications

  • Follistim AQ Cartridge (follitropin beta injection) – Limit of 2700 IU
  • Ganirelix Acetate Injection (brand name) – Limit of 5 syringes
  • Pregnyl (chorionic gonadotropin for injection, USP) – Limit of 1 vial

Eligibility Requirements

  • Cash-paying patients without insurance coverage for eligible fertility medications
  • Female patients requiring cancer treatment that may affect fertility
  • No prior chemotherapy
  • Completed Oncologist Form
  • Current proof of income (IRS 1040 tax form)
  • Additional terms and restrictions apply

Application Instructions*

  1. Download the Oncologist Form and ask your oncologist to complete the form to certify your eligibility.
  2. Apply online. You will be asked to upload the completed Oncologist Form and a current IRS 1040 tax form.
  3. Submit your enrollment application. You will receive an email notification within 24-48 hours regarding your application status.

*Submission of an application and completed Oncologist Form does not guarantee program approval. Eligibility is determined by ReUnite.

ReUnite Oncofertility Oncologist Form

For more information about this program, call 1-800-515-3784 or email info@mdrusa.com.